Quantcast

Latest Prostate cancer Stories

2014-03-24 16:22:35

NORWALK, Conn., March 24, 2014 /PRNewswire/ -- UBM Medica US announces that Cancer Network, the online home of the journal ONCOLOGY presents a special report on the most prevalent cancer for men, prostate cancer. Cancer Network, a leading online community for oncologists and others who treat cancer, offers news, blogs, and podcasts about the latest clinical findings and best practices in oncology. As part of our special series on prostate cancer, we present: -- An interview with...

2014-03-24 12:30:43

Prostate Size, Severe Symptoms Not a Barrier to Success, Say Interventional Radiologists About Nonsurgical Prostate Artery Embolization SAN DIEGO, March 24, 2014 /PRNewswire-USNewswire/ -- Shrinking the prostate without surgery can provide long-term relief to men with this common condition that causes annoying symptoms, such as frequent trips to the bathroom, suggests a study of nearly 500 men. According to research being presented at the Society of Interventional Radiology's 39th...

2014-03-24 08:29:09

NORTH HOLLYWOOD, Calif., March 24, 2014 /PRNewswire/ -- Online health retailer IMS Supplements, Inc. has recently been approved to display a doctor's seal of approval, a major benefit granted by consumer protection service Doctor Trusted. Photo - http://photos.prnewswire.com/prnh/20140324/PH88672 Many consumers have seen television commercials in addition to radio ads for prostate products. When you choose a prostate supplement or any product you put into your body a celebrity...

2014-03-23 23:01:51

An Italian study of 22 clinical trials contains some good news and some bad news for diabetic patients treated with the drug Actos. Raleigh, NC (PRWEB) March 23, 2014 Cancer Monthly is reporting on the results of an Italian Meta-Analysis involving more than 13,197 patients who had taken either the diabetes drug Actos or another thiazolidinedione called rosiglitazone. Researchers at the Careggi Teaching Hospital in Florence, Italy scoured the medical literature for both published and...

2014-03-23 23:01:08

According to the initial clinical investigation results at the Department of Urology at The Mikaelian Institute of Surgery in Armenia, men with enlarged prostate have to start benign prostatic hyperplasia (BPH) treatment with Dr. Allen’s Device in order to shrink the prostate and get relieve from the lower urinary tract symptoms, states Fine Treatment. London, GB (PRWEB) March 23, 2014 Preliminary results of clinical studies of men with BPH conducted at the Department of Urology at The...

2014-03-22 23:00:48

Since April 2013, over 250 men with chronic non-malignant prostate problems have started a supervised treatment with Dr. Allen's Device for Prostate Care at the Department of Urology at The Mikaelyan Institute of Surgery in Armenia. The preliminary trial results show that men can recover from chronic prostatitis/chronic pelvic pain syndrome CP/CPPS by using Dr. Allen’s Device only, highlights Fine Treatment. London, GB (PRWEB) March 22, 2014 The initial results of a clinical...

2014-03-21 23:04:09

Saint Luke’s Mid America Heart Institute researchers question the purported link between fish oil supplements and an increased risk of prostate cancer. Kansas City, Missouri (PRWEB) March 21, 2014 Consumption of long chain omega-3 fatty acids – from fish oil and fish oil supplements – have long been considered to provide a variety of health benefits. However, recent articles in the mainstream media have suggested that rather than providing a health benefit, consumption of omega-3...

2014-03-21 23:01:25

Preliminary results of clinical studies of men with benign prostatic hyperplasia (BPH) conducted at the Department of Urology at The Mikaelian Institute of Surgery have shown that enlarged prostate can be reduced to its normal size exclusively by using the device and treatment method invented by Dr. Simon Allen. The Thermobalancing therapy has demonstrated effectiveness without drugs and surgeries. London, UK (PRWEB) March 21, 2014 Men with BPH were re-examined in March 2014 after using...

2014-03-21 08:25:00

Leveraging Proprietary Mucoadhesive Polymer Hydrogel Technology to Expand Product Offerings; Seeking Global Marketing Partners NEW YORK, March 21, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) announced that it has advanced development of a new proprietary product, called ProctiGard(TM), for the treatment of radiation proctitis. Radiation proctitis ("RP") is a significant unmet medical need, with no well-established standard of care. It is estimated that there are...

2014-03-20 23:02:41

Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. Sacramento, CA (PRWEB) March 20, 2014 Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted immune response and reduced the number of tumors in mice with lung cancer. The...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related